Stockreport

BioMarin updated 2024 guidance sees EPS raise, but no change to revenue [Seeking Alpha]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF For the year, the company is still projecting revenues of $2.7B-$2.8B. Consensus is $2.76B. Non-GAAP diluted EPS guidance was raised to $2.75-$2.95 from $2.60-$2.80. [Read more]